Medical equipments, pharmaceuticals and personal care products

Description

A decision has been made that St. Olavs Hospital HF (Org. no. 883 974 832) shall procure 2 ABL800 blood gas instruments for the main intensive care at St. Olavs Hospital HF. The main intensive care is a department that particularly depends on blood gas for its daily treatment of patients in a safe and correct way. The results of the blood gas analysis decide a lot of the critical treatment that is chosen for the patient in question. The main intensive care treats critically ill patients and the nurses cannot, therefore, leave a patient for long periods of time, as the patients shall be observed around the clock. For this reason, it is important to have a system that minimises the time that is used in analysing blood gases in the department, so that the person who is analysing the sample can quickly return to their patient. It is, therefore, also important that the actual analysing shall be as automated as possible, which will further shorten the time that the nurses must be away from their patients. Due to a very large number of samples (the number of samples per month), which on average is approx. 2 400 samples per months, the department needs a system with high running time (the time that the instrument is ready for analysing samples). The instrument must also have great operational reliability and stability both as regards consumables and analysis quality in order to avoid having to go to a neighbouring instrument to analyse a sample. ABL 800 is the only instrument that offers all of these solutions. The instrument is very robust and it tolerates a large number of samples in a short time. It has good running time, with a calculated down time per 30 days of 1 240 minutes, excluding control runs. ABL 800 also has the lowest error rate for consumables of blood gas instruments in this class, with an error rate of only 2 %, as well as very good and stable analysis quality. The instrument is delivered with flexQ-module, which enables automation of the entire analysis process, as well as automatic mixing of the sample before analysis. This option for such automation does not currently exist in other blood gas instruments. In addition to the above, the procurement also gives financial savings as regards large amounts of samples in a short time. The procurement's value, including equipment specific consumables in the equipment's lifetime (7 years) is estimated to approx. NOK 3 210 000 excl. VAT.